Bile salt toxicity aggravates cold ischemic injury of bile ducts after liver transplantation in Mdr2+/- mice.
Intrahepatic bile duct strictures are a serious complication after orthotopic liver transplantation (OLT). We examined the role of endogenous bile salt toxicity in the pathogenesis of bile duct injury after OLT. Livers from wild-type mice and mice heterozygous for disruption of the multidrug resistance 2 Mdr2 gene (Mdr2+/-) were transplanted into wild-type recipient mice. Mdr2+/- mice secrete only 50% of the normal amount of phospholipids into their bile, leading to an abnormally high bile salt/phospholipid ratio. In contrast to homozygous Mdr2-/- mice, the Mdr2+/- mice have normal liver histology and function under normal conditions. Two weeks after OLT, bile duct injury and cholestasis were assessed by light and electron microscopy, as well as through molecular and biochemical markers. There were no signs of bile duct injury or intrahepatic cholestasis in liver grafts from wild-type donors. Liver grafts from Mdr2+/- donors, however, had enlarged portal tracts with cellular damage, ductular proliferation, biliostasis, and a dense inflammatory infiltrate after OLT. Parallel to this observation, recipients of Mdr2+/- livers had significantly higher serum transaminases, alkaline phosphatase, total bilirubin, and bile salt levels, as compared with recipients of wild-type livers. In addition, hepatic bile transporter expression was compatible with the biochemical and histological cholestatic profile found in Mdr2+/- grafts after OLT. In conclusion, toxic bile composition, due to a high biliary bile salt/phospholipid ratio, acted synergistically with cold ischemia in the pathogenesis of bile duct injury after transplantation.
Hoekstra
Harm
H
Swiss HPB Center, Department of Visceral and Transplant Surgery, University Hospital Zurich, Switzerland.
Porte
Robert J
RJ
Tian
Yinghua
Y
Jochum
Wolfram
W
Stieger
Bruno
B
Moritz
Wolfgang
W
Slooff
Maarten J H
MJ
Graf
Rolf
R
Clavien
Pierre A
PA
D018435:ATP Binding Cassette Transporter, Subfamily B / Q000235:genetics / Q000502:physiology*; D000818:Animals; D001647:Bile Acids and Salts / Q000502:physiology*; D001649:Bile Duct Diseases / Q000209:etiology* / Q000473:pathology; D001652:Bile Ducts / Q000098:blood supply* / Q000473:pathology; D050377:Cold Ischemia / Q000009:adverse effects*; D016031:Liver Transplantation / Q000009:adverse effects*; D051379:Mice; D012720:Severity of Illness Index; D000097202:ATP-Binding Cassette Sub-Family B Member 4
D018435:ATP Binding Cassette Transporter, Subfamily B; D001647:Bile Acids and Salts; D000097202:ATP-Binding Cassette Sub-Family B Member 4